Braintree Laboratories
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Braintree Laboratories sits in the top decile of US sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count).
Braintree Laboratories: 49 sponsored US clinical trials, none currently recruiting.
Braintree Laboratories sponsors 49 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 48 completed. 33 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Colonoscopy, with 4 trials.
Top-decile sponsor footprint
Braintree Laboratories ranks in the top decile of sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 49 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
49 total, page 1 of 1
A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
NCT05890001
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
NCT05587309
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
NCT04446299
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
NCT04446312
An Open-Label Preference Evaluation of BLI800
NCT04214301
A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy
NCT03404401
A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects
NCT03328507
A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
NCT03261960
BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects
NCT03103581
A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects
NCT03023085
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
NCT02819310
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
NCT02822508
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
NCT02819297
A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
NCT02819323
A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
NCT02820714
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects
NCT02665728
A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
NCT02604680
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
NCT02481947
A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy
NCT02376465
Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
NCT02189850
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
NCT01815450
BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
NCT01786629
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
NCT01687985
A Safety Study of 3 Different Bowel Cleansing Preparations
NCT01501513
A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
NCT01442363
BLI801 Laxative in Constipated Adults
NCT01301781
BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
NCT01241331
F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
NCT00857272
BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
NCT00856843
BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
NCT00756548
BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
NCT00756977
A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults
NCT00583154
A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children
NCT00583609
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
NCT00583713
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
NCT00503607
BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
NCT00503815
A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population
NCT00425594
Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)
NCT00373334
A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
NCT00319670
An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
NCT00278967
Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.
NCT00164177
Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation
NCT00153140
Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients
NCT00153153
An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients
NCT00164125
PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children
NCT00153114
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
NCT00153127
A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.
NCT00164151
HalfLytely Bowel Prep System for Colonoscopy
NCT00164164
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 14 |
| Phase 3 | 20 |
| Phase 4 | 13 |
Therapeutic Areas
How the Braintree Laboratories archive is shaped
49 indexed studies, none listed as recruiting (0% open); 48 completed (98%).
Phase mix: 33 late (III/IV) vs 16 early (I/II) (later-stage heavy).
Top condition: Colonoscopy (4 trials), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Braintree Laboratories: archived-pipeline peers nationwide
Peers matched on 49 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Braintree Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 49 archived trials
- Alnylam Pharmaceuticals · 49 trials · 29% recruiting
- argenx · 49 trials · 39% recruiting
- Cynosure · 49 trials · 2% recruiting
- Mirati Therapeutics · 49 trials · 10% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Braintree Laboratories page
49 registered trials is a research-attention snapshot, not an endorsement of Braintree Laboratories or any single study.
- None of Braintree Laboratories's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Colonoscopy is the condition Braintree Laboratories studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colonoscopy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Braintree Laboratories pipeline card: 49 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.